347 related articles for article (PubMed ID: 8182121)
1. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.
Ishibashi S; Goldstein JL; Brown MS; Herz J; Burns DK
J Clin Invest; 1994 May; 93(5):1885-93. PubMed ID: 8182121
[TBL] [Abstract][Full Text] [Related]
2. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.
Zabalawi M; Bhat S; Loughlin T; Thomas MJ; Alexander E; Cline M; Bullock B; Willingham M; Sorci-Thomas MG
Am J Pathol; 2003 Sep; 163(3):1201-13. PubMed ID: 12937162
[TBL] [Abstract][Full Text] [Related]
3. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
Draijer R; Volger OL; Dahlmans VE; de Wit EC; Havekes LM; Princen HM
Biochem Pharmacol; 2002 May; 63(9):1755-61. PubMed ID: 12007578
[TBL] [Abstract][Full Text] [Related]
4. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
[TBL] [Abstract][Full Text] [Related]
5. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
[TBL] [Abstract][Full Text] [Related]
6. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis.
Wu L; Vikramadithyan R; Yu S; Pau C; Hu Y; Goldberg IJ; Dansky HM
J Lipid Res; 2006 Oct; 47(10):2215-22. PubMed ID: 16840797
[TBL] [Abstract][Full Text] [Related]
7. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
[TBL] [Abstract][Full Text] [Related]
8. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
[TBL] [Abstract][Full Text] [Related]
9. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.
Merat S; Fruebis J; Sutphin M; Silvestre M; Reaven PD
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):B85-94. PubMed ID: 10737683
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7242-6. PubMed ID: 8692976
[TBL] [Abstract][Full Text] [Related]
11. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
[TBL] [Abstract][Full Text] [Related]
12. Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.
Khan-Merchant N; Penumetcha M; Meilhac O; Parthasarathy S
J Nutr; 2002 Nov; 132(11):3256-62. PubMed ID: 12421837
[TBL] [Abstract][Full Text] [Related]
13. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
14. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
[TBL] [Abstract][Full Text] [Related]
15. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Semenkovich CF; Coleman T; Daugherty A
J Lipid Res; 1998 Jun; 39(6):1141-51. PubMed ID: 9643345
[TBL] [Abstract][Full Text] [Related]
16. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
17. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J
J Clin Invest; 1993 Aug; 92(2):883-93. PubMed ID: 8349823
[TBL] [Abstract][Full Text] [Related]
18. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
[TBL] [Abstract][Full Text] [Related]
19. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
Kowala MC; Recce R; Beyer S; Gu C; Valentine M
Atherosclerosis; 2000 Apr; 149(2):323-30. PubMed ID: 10729382
[TBL] [Abstract][Full Text] [Related]
20. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
